Baylor University Medical Center at Dallas’ acute mechanical circulatory
support program for the treatment of heart failure offers patients a full
array of FDA-approved ventricular assist devices. A ventricular assist
device (VAD) is a mechanical pump that is surgically implanted to assist
the heart pumping blood throughout the body. These devices can be
used as a bridge-to-transplant or a long-term therapy. When used as a
bridge-to-transplant, VADs help the patient’s heart pump until a donor
heart becomes available. For those who are not candidates for heart
transplantation, these devices serve as a long-term destination therapy in
end-stage heart failure patients. To prepare for this therapy, Baylor Dallas
provides training to the patient and caregivers on the information needed
to care for himself or herself and any medical devices at home.
53
Patients benefitted
from a ventricular assist
device (FY17)
In line with Baylor Dallas’ rich histo ry of research and innovation,
Baylor Annette C. and Harold C. Simmons Transplant Institute is the
8th largest enrollment site in the nation for the Momentum III U.S.
IDE clinical study. The study is aimed at evaluating the safety and
VOLUMES FOR ECMO
effectiveness of the HeartMate 3™ Left Ventricular Assist System against
SUPPORT
the HeartMate II® as both a bridge-to-transplantation and destination
Percent per type therapy. This is the first LVAD study designed with both short-term
40
and long-term endpoints in mind. Candidates for the
38
35
trial include any patient who is indicated for
an LVAD, including those with stage D
52.2%
30
congestive heart disease secondary to
28
47.8%
25
a weakened heart, usually caused by
24
coronary artery disease, prior heart
20
attack, or viral cardiomyopathy.
15
Cardiac ECMO
10
Respiratory ECMO
59*
*Fiscal Year 2017
Some advanced heart disease patients are too sick to undergo surgery.
In support of these patients, Baylor University Medical Center at Dallas
has continued to develop and expand the extracorporeal membrane
oxygenation (ECMO) program. ECMO is a miniaturized heart-lung
machine that removes the patient’s blood, infuses it with oxygen,
removes carbon dioxide, and returns the patient’s blood in a continuous
cycle. Whereas some heart-assist devices only support one ventricle,
ECMO supports both ventricles. The circulation of oxygenated blood
around the body allows the patient’s medical team, including dedicated
ECMO specialists, to determine the best course of action to increase the
patient’s chance of survival.
FY15 FY16 FY17
Percent per type
38
52.2%
47.8%
Cardiac ECMO 54
Respiratory ECMO 59*
*Fiscal Year 2017
A total of 113 patients received ECMO support in fiscal year 2017,
making the Baylor Dallas program one of the busiest in the nation.
Timely action for these critically ill patients is supported through
collaborations with regional hospitals for patient transports. Through a
collaboration with CareFlite® for helicopter and fixed-wing capabilities,
Baylor Dallas is the only North Texas health care facility offering
transportation for adult patients on ECMO. In addition, the program
at Baylor Dallas serves as a training facility for ECMO support to other
North Texas facilities.
FY17
HeartMate 3 image courtesy of St. Jude Medical
EXTRA CORPOREAL LIFE SUPPORT
5
0
54
MECHANICAL ASSIST DEVICE PROGRAM
61